Cdc42EP4 Polyclonal Antibody

Rabbit Anti-Cdc42EP4 Polyclonal Antibody

Product Specifications

Background

The product of CDC42EP4 is a member of the CDC42-binding protein family. Members of this family interact with Rho family GTPases and regulate the organization of the actin cytoskeleton. This protein has been shown to bind both CDC42 and TC10 GTPases in a GTP-dependent manner. When overexpressed in fibroblasts, this protein was able to induce pseudopodia formation, which suggested a role in inducing actin filament assembly and cell shape control.

CAS Number

9007-83-4

Product Name Alternative

CDC42EP4; BORG4; CEP4; Cdc42 effector protein 4; Binder of Rho GTPases 4

Gene ID

23580

Accession Number

Q9H3Q1

Reactivity

Human, Mouse

Immunogen

Synthesized peptide derived from the Internal region of human Cdc42EP4 at AA rangle: 180-260

Clonality

Polyclonal

Tag

Cdc42 effector protein 4

Applications

WB, IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

36kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

Cdc42EP4 Polyclonal Antibody detects endogenous levels of Cdc42EP4 protein.

Observed Molecular Weight

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000; IHC 1:100-1:300; ELISA 1:20000; IF 1:50-200